The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 01, 2021
Filed:
Apr. 04, 2018
Applicant:
Ospedale San Raffaele Srl, Milan, IT;
Inventors:
Francesca D'Addio, Milan, IT;
Paolo Fiorina, Milan, IT;
Assignee:
Ospedale San Raffaele Srl, Milan, IT;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 45/06 (2006.01); C07K 16/18 (2006.01); G01N 33/68 (2006.01); A61K 31/713 (2006.01); A61K 47/60 (2017.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
A61K 38/177 (2013.01); A61K 31/713 (2013.01); A61K 38/1709 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); A61P 3/10 (2018.01); C07K 16/18 (2013.01); G01N 33/6893 (2013.01); C07K 2317/76 (2013.01); G01N 2333/4745 (2013.01); G01N 2800/042 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to the role of the IGFBP3/TMEM219 axis in the onset of diabetes and the related use of IGFBP3/TMEM219 axis inhibitors for the treatment and/or prevention of diabetes. The invention also relates to a method to identify a subject at risk of developing Type 1 and/or Type 2 diabetes and relative kit.